Skip to content
The Nexus
DossierENTITY

Richard Gonzalez

Coverage of Richard Gonzalez in the Nexus archive.

Earliest in view: May 26 · 08:30 UTCMost recent: May 26 · 08:30 UTC
Co-mentioned in this coverage
John Cornynperson1AbbVieorganization1Humiratopic1Senate Committee on Financeorganization1rheumatoid arthritistopic1inflammatory bowel diseasetopic1FDAorganization1
Recent coverage
  • BUSINESSMay 26 · 08:30 UTCSTAT NEWS
    Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies

    Sen. John Cornyn questioned AbbVie CEO Richard Gonzalez during a 2019 congressional hearing about the company's 136 patents on Humira, a drug with the same active molecule used to treat multiple conditions. Gonzalez defended the patents as 'innovations,' extending patent protection beyond the original 2016 expiry. The exchange highlights concerns about pharmaceutical companies leveraging patent portfolios to maintain monopolies.